Verastem, Inc. (VSTM) stock
VSTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.33−0.53 (-7.73%)
Close on Nov 20, 2026Market cap $573.27MP/E –Yield –
Verastem gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Verastem's gross profit for the twelve months ending Dec 31, 2018 was $26.55M. For fiscal 2018 it was $26.55M.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $26.55M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2020 | Sep 30, 2020 | $47.46M | – |
| Q1 FY2019 | Mar 31, 2019 | $1.51M | – |
| Q4 FY2018 | Dec 31, 2018 | $1.09M | – |
| Q3 FY2018 | Sep 30, 2018 | $15.46M | – |
See a number that looks wrong?